Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on September 30, 2025, that on September 29, 2025, it repurchased 450,000 of its Ordinary Shares at $1.52 per share. These shares will be held in treasury. Following the transaction, the company's issued Ordinary Share capital is 345,967,440, with 18,643,791 shares held in treasury, resulting in total voting rights of 327,323,649. The buyback was authorized at the Annual General Meeting in June 2025, allowing for repurchase of up to 14.99% of Ordinary Shares. The company intends to hold any repurchased shares in treasury and has appointed Deutsche Numis as its broker for the buyback transactions.

Disclaimer*

UK 100

Latest directors dealings